Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (81-90 of 466) with videos related to

Pageof 47
Sort By:
The American Journal of Gastroenterology|March 4, 2005
Estimation of utilities for chronic hepatitis C from SF-36 scoresHla-Hla Thein, Murray Krahn, John M Kaldor, et al.
Hepatology (Baltimore, Md.)|June 20, 2008
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regressionHla-Hla Thein, Qilong Yi, Gregory J Dore, et al.
Australian Family Physician|November 5, 2003
Epidemiology of hepatitis C virus infection in AustraliaGregory J Dore, Margaret MacDonald, Matthew G Law, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?Jason Grebely, Bart Grady, Behzad Hajarizadeh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirementsJason Grebely, Gail V Matthews, Andrew R Lloyd, et al.
Addiction (Abingdon, England)|December 16, 2022
Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapiesJenny Iversen, Handan Wand, Hamish McManus, et al.
BMC Public Health|January 26, 2011
Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyHeather F Gidding, Gregory J Dore, Janaki Amin, et al.
Antiviral Therapy|December 3, 2003
Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settingsGregory J Dore, Anthony J Freeman, Matthew Law, et al.
Lancet (London, England)|September 23, 2023
Hepatitis CMarianne Martinello, Sunil S Solomon, Norah A Terrault, et al.
Journal of Gastroenterology and Hepatology|May 2, 2002
Is severe liver disease a common outcome for people with chronic hepatitis C?Gregory J Dore, Anthony J Freeman, Matthew Law, et al.
Pageof 47

Showing results (81-90 of 466) with videos related to

Sort By:
Pageof 47
The American Journal of Gastroenterology|March 4, 2005
Estimation of utilities for chronic hepatitis C from SF-36 scoresHla-Hla Thein, Murray Krahn, John M Kaldor, et al.
Hepatology (Baltimore, Md.)|June 20, 2008
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regressionHla-Hla Thein, Qilong Yi, Gregory J Dore, et al.
Australian Family Physician|November 5, 2003
Epidemiology of hepatitis C virus infection in AustraliaGregory J Dore, Margaret MacDonald, Matthew G Law, et al.
Hepatology (Baltimore, Md.)|August 10, 2013
Disease progression during advanced fibrosis: IL28B genotype or HCV RNA levels?Jason Grebely, Bart Grady, Behzad Hajarizadeh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2013
Elimination of hepatitis C virus infection among people who inject drugs through treatment as prevention: feasibility and future requirementsJason Grebely, Gail V Matthews, Andrew R Lloyd, et al.
Addiction (Abingdon, England)|December 16, 2022
Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapiesJenny Iversen, Handan Wand, Hamish McManus, et al.
BMC Public Health|January 26, 2011
Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyHeather F Gidding, Gregory J Dore, Janaki Amin, et al.
Antiviral Therapy|December 3, 2003
Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settingsGregory J Dore, Anthony J Freeman, Matthew Law, et al.
Lancet (London, England)|September 23, 2023
Hepatitis CMarianne Martinello, Sunil S Solomon, Norah A Terrault, et al.
Journal of Gastroenterology and Hepatology|May 2, 2002
Is severe liver disease a common outcome for people with chronic hepatitis C?Gregory J Dore, Anthony J Freeman, Matthew Law, et al.
Pageof 47